Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

442
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
442
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

345
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
345
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

238
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
238

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

High-Entropy Phosphide-Polymer Nanointerfaces Enable Adaptive Li<sup>+</sup> Transport for High-Performance Solid-State Li Metal Batteries.

Angewandte Chemie (International ed. in English)·2026
Same author

Erianin ameliorates liver fibrosis through the PRDX3/NLRX1 axis.

European journal of pharmacology·2026
Same author

Efficacy and safety of combination immunotherapy and targeted therapy as second-line and subsequent treatments for advanced biliary tract cancer: A systematic review and meta-analysis.

Medicine·2026
Same author

EDRNet-based adolescent idiopathic scoliosis screening method using bare-back images.

BMC medical informatics and decision making·2026
Same author

miR-29a-3p targets the PI3K/Akt signaling pathway to suppress inflammation and MMP-9-dependent matrix degradation in spinal tuberculosis.

Journal of orthopaedic surgery and research·2026
Same author

Diselenide-bridged mesoporous silica nanoplatform for baicalin delivery facilitates spinal cord injury repair via CHCHD2-mediated mitochondrial homeostasis restoration.

Materials today. Bio·2026

相关实验视频

Updated: Sep 10, 2025

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.1K

ALKBH5抑制miR-29a-3p的表达,从而加剧与脊髓结核相关的炎症反应

Mengqi Zhu1,2, Zhengyong Tao1,2, XingYu Duan1,2

  • 1Department of Orthopedic, General Hospital of Ningxia Medical University, Ningxia Hui Autonomous Region, No.804 Shengli Street, Yinchuan, 750004, China.

Journal of orthopaedic surgery and research
|August 21, 2025
PubMed
概括

在脊柱结核病中,ALKBH5 抑制miR- 29a- 3p,促进炎症. 针对这种途径可能为脊柱结核提供新的治疗方法.

关键词:
其他:炎症反应脊柱结核病miR-29a-3p 其他

更多相关视频

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.7K
Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

571

相关实验视频

Last Updated: Sep 10, 2025

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.1K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.7K
Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

571

科学领域:

  • 分子生物学
  • RNA 修改
  • 免疫学

背景情况:

  • N6-甲基氨酸 (m6A) 是一种普遍存在的RNA修饰.
  • 在脊柱结核病 (STB) 中m6A的作用尚不完全理解.
  • 在STB患者中,miR- 29a- 3p的表达有所差异.

研究的目的:

  • 在STB中研究ALKB同类5 (ALKBH5) 的miR-29a-3p调节.
  • 阐明ALKBH5对STB炎症反应的影响机制.

主要方法:

  • 来自STB患者和对照者的组织样本分析.
  • qRT-PCR,免疫组织化学和免疫光测定ALKBH5和miR-29a-3p的表达.
  • 为了验证监管机制,MeRIP,Western blot和ELISA进行了测试.

主要成果:

  • 在STB中,ALKBH5上调,miR- 29a- 3p下调.
  • 通过m6A修饰,ALKBH5直接向并抑制miR-29a-3p的成熟.
  • 抑制miR- 29a- 3p促进了炎症因子 (TNF- α,IL- 1β,IL- 17A),而过度表达则抑制了它们.

结论:

  • 在STB中抑制miR-29a-3p的表达.
  • 这种抑制促进炎症因子的释放,有助于STB的发病.
  • 通过ALKBH5调节miR-29a-3p是STB的潜在治疗点.